Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68180-857

8 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68180-857). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 01)

Molecular Structure (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 01)
Chemical structure diagram showing the molecular structures of Levonorgestrel and Ethinyl Estradiol, the active ingredients in the product. The image depicts the arrangement of atoms and bonds specific to these two steroid compounds.*
FDA Label Image

Image 02 (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 02)

Image 02 (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 02)
A bar chart categorizing participants by age groups (15-24, 25-34, 35-44, 45+) and smoking status. Four groups are compared: ever-users nonsmokers, controls nonsmokers, ever-users smokers, and controls smokers, with ever-users smokers in the 45+ age group showing the highest value at 200.*
FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptive Use (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 03)

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptive Use (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 03)
A forest plot chart showing effect estimates (odds ratios or relative risks) with confidence intervals from various women's health studies on contraceptive use, comparing ever use and current use. The horizontal axis represents effect estimates ranging from approximately -1.5 to 2, with several studies' estimates plotted relative to a reference value of 1.*
FDA Label Image

Image (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 04)

FDA Label Image

Wallet (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 05)

Wallet (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 05)
An instructional diagram showing a 28-day pill pack schedule for Levonorgestrel and Ethinyl Estradiol by Lupin Pharmaceuticals, Inc. The diagram is arranged in four rows labeled Week 2 to Week 4, with circles representing daily pill doses organized under days of the week from Sunday to Saturday. Arrows indicate the direction for daily pill intake starting from Sunday in the top row.*
FDA Label Image

Image (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 06)

FDA Label Image

Blister Label (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 07)

Blister Label (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 07)
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP by Lupin Pharmaceuticals, Inc. The lidding foil side lists active ingredient strengths as 0.05 mg/0.03 mg; 0.075 mg/0.04 mg; and 0.125 mg/0.03 mg. Includes storage instructions, manufacturer info (Lupin Limited, India), and barcode. The forming foil/PVC side features a 28-day tablet calendar with days of the week and directional arrows for usage starting on Sunday and progressing through four weeks.*
FDA Label Image

Carton Label (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 08)

Carton Label (2cc1d4cc 8398 4ed8 Bca0 313c99e8aeef 08)
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP by Lupin Pharmaceuticals, Inc. The label shows a triphasic regimen with strengths of 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, and 0.125 mg/0.03 mg. The package contains 3 blisters of 28 tablets each. It includes distributor and manufacturer information, barcode, and a note that the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.